HLA-DRB1: A new potential prognostic factor and therapeutic target of cutaneous melanoma and an indicator of tumor microenvironment remodeling.

Deng, Huiling; Chen, Yuxuan; Wang, Jiecong; An, Ran

Deng, Huiling; Chen, Yuxuan; Wang, Jiecong; An, Ran.

Afiliación

Deng H; Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
Chen Y; Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
Wang J; Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.
An R; Department of Plastic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, PR China.

PLoS One ; 17(9): e0274897, 2022.

Article en En | MEDLINE | ID: mdl-36129956

Asunto(s)

Melanoma; Neoplasias Cutáneas; Regulación Neoplásica de la Expresión Génica; Cadenas HLA-DRB1/genética; Humanos; Linfotoxina beta/genética; Melanoma/genética; Pronóstico; Factor Regulador X1/genética; Neoplasias Cutáneas/genética; Microambiente Tumoral/genética; Melanoma Cutáneo Maligno

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Prognostic_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google